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Abstract
Predictive modeling of blood flow and pressure have numerous applications ranging from
non-invasive assessment of functional significance of disease to planning invasive procedures.
While several such predictive modeling techniques have been proposed, their use in the
clinic has been limited due in part to the significant time required to perform virtual in-
terventions and compute the resultant changes in hemodynamic conditions. We propose a
fast hemodynamic assessment method based on first constructing an exploration space of
geometries, tailored to each patient, and subsequently building a physics driven reduced
order model in this space. We demonstrate that this method can predict fractional flow
reserve derived from coronary computed tomography angiography in response to changes
to a patient-specific lumen geometry in real time while achieving high accuracy when com-
pared to computational fluid dynamics simulations. We validated this method on over 1300
patients that received a coronary CT scan and demonstrated a correlation coefficient of 0.98
with an error of 0.005 ± 0.015 (95% CI: (-0.020, 0.031)) as compared to three-dimensional
blood flow calculations.
1 Introduction
Patient-specific modeling of blood flow has emerged as a tool with increasing importance in the
diagnosis and treatment of patients with coronary artery disease [1] [2] [3] [4] [5] [6]. A unique
strength of simulation methodologies lie in the predictive modeling of hemodynamics in response
to unplanned events (such as progression or regression of lesions), or the outcome of planned
procedures (such as surgical intervention) [7]. For predictive modeling to be used in the cardiac
catheterization laboratory or other invasive procedures, it is imperative that the modeling tools
can generate results in seconds.
In this work, we address one of the most challenging aspects of interventional planning for
patients with coronary artery disease - Which coronary artery stenoses are having the great-
est impact on blood flow? Due to the vastly different anatomies and lesion morphologies in a
normal patient population, it is infeasible to have a preset approach for the treatment strategy.
Therefore, the planning of invasive procedures in a patient is left to the knowledge, intuition
and experience of the clinician based on available data. This paper describes a patient-specific
framework that can virtually model different scenarios and help the physician evaluate various
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2strategies by identifying and ranking the impact each coronary artery stenosis has on the blood
flow. We describe a fast and accurate tool derived from a patient specific coronary CT angiog-
raphy scan that is applicable in a clinical setting. The clinical metric computed is the fractional
flow reserve (FFR) which is measured in the cardiac catheterization lab with a pressure wire in-
serted in the patient’s coronary arteries. FFR is ratio of the time-averaged pressure downstream
of a coronary artery stenosis to a time-averaged reference aortic pressure under conditions of
maximum hyperemia typically induced by the intravenous administration of adenosine. FFR
computed from coronary computed tomography data (FFRCT) is derived by simulating blood
flow and pressure in a patient-specific anatomic model using computational fluid dynamics (CFD)
methods [1].
Fast assessment of blood flow has been an active area of research in the past several years.
Recently, many successful methods have evolved that apply simulation methodologies for the
estimation of clinical quantities of interest from medical imaging data. For instance, artificial
intelligence methods have been applied to quantify hemodynamics from phase contrast MRI
scans [8], or to quantify information from handheld ultrasound devices [9]. While these techniques
help in the automation, miniaturization or reproducibility in the extraction of information, the
approach, fundamentally, is to quantify information already present in the medical images. In
contrast, this paper focuses on predictive modeling of the effect of treatment, for which no current
patient-specific non-invasive alternatives exist.
The development of reduced order models for the simulation of blood flow has been the focus
of several studies [10, 11, 12, 13, 14, 15, 16]. Kassab and colleagues [17] proposed an analytical
model based on the conservation of energy, and considered various energy losses associated with
a lumen narrowing such as convection and diffusion and also accounted for the losses associated
with sudden constriction and expansion in lumen area. They demonstrated the performance on
a tube-like stenosis model, however calculation of some of the higher order geometric quantities
(higher order gradients of radius or area) accurately on patient-specific geometries is not possible
due to the imaging resolution. Schrauwen et al. [18] [19] improved upon the traditional reduced
order models that assume parabolic velocity by deriving a velocity profile based on the geometry
and flow, and validated it on straightened coronary arteries. However, the velocity profiles on
patient specific models with multiple bifurcations and interfering stenosis (effect of one stenosis
overlapping on another) can be significantly different. Nithiarasu and colleagues [20] [21] [22]
developed reduced order models that accounted for intramyocardial pressure and material prop-
erties of the arterial wall, and evaluated performance in a virtual cohort of 30 lesions with the
same global geometry. Itu et al. [23] proposed a machine learning approach for assessment of
fractional flow reserve and verified it against another reduced order model on synthetic data.
While these approaches have helped immensely in understanding how the complex physics of
fluids can be captured with a reduced order system, these are not applicable for clinical trans-
lation due to the high demands on accuracy, latency and robustness. Our goal in this paper is
to develop an algorithm that meets these requirements by demonstrating a very high accuracy
over a large cohort of patient-specific models with diverse charecteristics.
The framework we propose uses a response surface [24] methodology and can predict the
results of the simulations significantly faster and with an accuracy close to the high-fidelity sim-
ulations. The reduced order model is parameterized using the response surface built using a full
order high fidelity high cost (HFHC) model performed at certain pre-set configurations. Sim-
ulations for the HFHC model may utilize all the information available about the system (such
as using the full spatial and temporal representation). A response surface is a mathematical
relationship between a quantity or quantities of interest or parameters, and an underlying rep-
3resentation or property, and have been built successfully for optimization problems [25]. The
pre-set configurations involve exploration of both the space of lumen geometries and flow rates.
As we increase the number of HFHC simulations used to construct the response surface, the
accuracy of the real-time predictive model becomes closer to the HFHC model within some error
margin. The response surface is used to explore the parameteric space by using a reduced order
model to interpolate the solutions. As a result of using physics driven interpolatory functions
derived from one-dimensional Navier-Stokes equations, our approach can mimic the results of the
computational fluid dynamics simulations better than other standard approaches such as using
polynomial or Lagrange interpolatory functions. The response surface is built to exactly match
the output of the high-fidelity model for the configurations where high-fidelity simulations were
performed.
We demonstrate that we can achieve excellent accuracy of the proposed method compared to
three-dimensional simulations for coronary blood flow using just four full order offline simulations.
We also evaluated the performance of the algorithm in predicting hemodynamics post stenting
or percutaneous coronary intervention (PCI) against invasive data for different lesion types. PCI
is the process of inserting a catheter with a balloon attached to restore and attain ideal lumen
geometry on a section of the blood vessel. We demonstrate that we can achieve high accuracy
against invasive data and that it can be used as an interactive tool to plan PCI.
We structure the paper as follows. In section 2, we describe the method behind the patient-
specific reduced order model. We describe the HFHC model and demonstrate how we can build
a real-time model using a set of HFHC models. In section 3, we demonstrate the performance of
the method against HFHC simulations. We use internal data that encompasses different lesion
types and FFR ranges to validate the model. We finally discuss implications of the method and
clinical translation in section 4.
2 Methods
Blood flow in the human arterial system can be effectively modeled using computational fluid
dynamics [1] [26]. These simulations can be performed on complex patient-specific anatomic
geometries that are reconstructed from coronary CT scans. The Navier-Stokes equations are used
to model blood flow and lumped parameter boundary conditions are prescribed that account
for the flow-pressure relationship in the microvasculature (vessels that are not visible in the
CCTA and therefore not modeled). Vignon-Clementel et al. [27] developed methods for coupling
boundary conditions using a circuit analogy of the microvasculature with the Navier-Stokes
equations and Kim et al. [28] specialized this method to modeling boundary conditions for
coronary arteries. Sankaran et al. used a set of ordinary differential equations [29] instead of
an analytical formulation for modeling blood flow in the microvasculature. In this work, we use
resistance (ratio of pressure drop to flow) boundary conditions for the microvascular network,
which are now routinely used in clinical practice [1] for the non-invasive assessment of FFRCT.
2.1 Computational Fluid Dynamics Model
The partial differential equations that model blood flow are represented as
N (u; p) = 0 in Ω (1)
4with the boundary conditions
b(u; p) = 0 in Γ (2)
where N is a non-linear differential operator modeling the Navier-Stokes equations, u are the
blood velocities and pressures, p represents fixed parameters, Ω is the problem domain and Γ is
the boundary of the domain. Since this model is already validated [2] [6] and used in clinical
practice for the calculation of FFRCT, we use the model governed by Equations 1 and 2 as our
HFHC model. Our goal in this work is to build a low cost model that is equivalent in accuracy
to the high fidelity model.
2.2 Reduced Order Models
A reduced order model of the partial differential equation approximates the operator, N , using
a simpler operator, Nˆ (e.g., ordinary differential equations), reduces the dimensionality of the
solution space u and/or reduces the dimensionality, of the problem space x, to a lower dimen-
sional space, xˆ, uˆ ≡ uˆ(xˆ) and simplifies the parameter set p to pˆ. In this case, x can be the
three dimensional representation of the geometry, and xˆ can be a corresponding one-dimensional
representation. The reduced order model problem is posed as follows, where we omit the spatial
dependence of u for clarity:
Nˆ (uˆ; pˆ) = 0 in Ωˆ (3)
with the boundary conditions
bˆ(uˆ; pˆ) = 0 in Γˆ (4)
The goal is to have uˆ(xˆ) be a good approximation of u(x) at xˆ. To achieve this, our approach
involves performing simulations of the original HFHC model for various geometries, Ω, bound-
ary domains, Γ and boundary conditions b(u; p) such that we can generate a response surface
and subsequently build a good approximating solution to the problem. In order to generate the
response surface and to ensure that we limit the exploration space to realistic geometries, we can
impose bounds on the domain of interest and the boundary conditions that the system will be
subject to. The original governing equation is solved in a series of domains, boundary conditions
and parameters.
((b1(.),Ω1,Γ1, p1) , ((b2(.),Ω2,Γ2, p2) , · · · , ((bM (.),ΩM ,ΓM , pM ) (5)
where M is the number of HFHC simulations performed. The results of the HFHC simulation
for each of these configurations are
(u1, u2, · · ·uM ) (6)
2.3 Physics driven response surface method
Any sampling method or quadrature method can be used for the selection of the M configura-
tions in Equation 5. As each simulation is computationally expensive, sampling methods such
as Monte-Carlo or latin hypercube sampling [30] tend to converge slowly in building an accurate
representation of the underlying function. Functional space methods, such as stochastic colloca-
tion or adaptive stochastic collocation methods [31] [32], can help accelerate the convergence for
a class of functions. However, they still demand significant calculation to generate the response
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Figure 1: (left) The reduced order model has two terms: a purely geometric term a(r) (parame-
terized by radius r) and a term that varies linearly with flowrate, Q, with a geometry dependent
slope, b(r). The coefficients are fit for each patient based on the patient geometry and idealized
geometry, and (right) four simulations are performed on two lumen segmentations (patient and
idealized) with two boundary conditions provided for each.
surface. We improve upon this further by regularizing the problem using a physics driven inter-
polation approach. Instead of using polynomials, which is commonly used for response surfaces,
we use the analytical solution from one-dimensional, steady state Navier-Stokes equations to
interpolate within the response surface. This enables employing a significantly reduced number
of simulations while still enabling equivalence with the HFHC simulations. In fact, we later
demonstrate that four HFHC simulations at the extremas of the exploration space are sufficient
to obtain equivalence with the full order model (refer Fig. 1).
A patient-specific response surface, R, is a mapping of the coefficients of the resistance given
a geometry, boundary conditions and parameters,
cˆ ∼ R(Ω, p, b(.),Γ) (7)
wherein cˆ captures the complexity of the original equations, enabling Nˆ to be a less complex
operator than N . The reduced order model, R, can be constructed such that uˆ(xˆ) ≡ u(xˆ) at the
M configurations where the HFHC simulations are performed. This approach lets us solve the
reduced order problem (refer to equations 3 and 4) for the unknowns uˆ, while ensuring that the
results are identical at the M configurations. The solution field uˆ contains only flowrates and
pressures instead of three velocity components and pressures. The reduced model is evaluated
only along the vessel centerlines along the vessel path instead of the entire volumetric patient-
specific geometry. The reduced order operator Nˆ contains the affine resistance model that
6relates flowrates to pressures and the flow-split model at bifurcations, which are explained in later
sections. Naturally, the approximations to the HFHC solutions at the intermediate configurations
will be better for larger M , but so will the time needed for the offline computations. These are
described in detail in the following sections.
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Figure 2: Illustration of the proposed method that builds a patient-specific reduced order model
which depends on both the anatomy and the physiologic state. Four simulations are used to
explore the embedding space of the lumen geometry and physiologic state. Hyperemia and
Superemia refer to different boundary conditions (or flowrates) and the colormap within the
window represents how the reduced order model resistance varies within the patient-specific
exploration space. Pd is the local pressure and Paorta is the reference aortic pressure.
2.4 Patient-specific ideal geometries
One of the novelties of our work is to build a patient-specific exploration space. To define the
bounds on the geometric domain, at each location in the coronary tree, we consider modifica-
tions wherein the vessel radius falls between the patient radius and the idealized radius. The
idealized model represents a model of a patient without regions of lumen narrowing (or “healthy
looking”). The idealized model is constructed by seeking a radius profile that is monotonically
non-increasing from the ostium to the leaves and is closest to the original radius profile, using a
robust objective function, formulated mathematically as
7rideal = arg minr∗ Σi
√
r∗i − rorig,i (8)
such that
r∗i ≤ rj if i is distal to j (9)
r∗i ≥ mi(optional) (10)
where rorig,i is the input radius, rideal,i is the idealized radius estimate and mi is an optional
minimal radius constraint at a vessel tree location i. For instance, mi can be set equal to rorig,i to
force the ideal model to be point-wise at least as large as the patient model. Idealized radius val-
ues rideal,i are optimized globally, over the entire coronary tree, through a dynamic programming
approach. Given idealized radius values, a patient-specific idealized 3D model is constructed by
dilating the original model from its local radius rorig,i to the target idealized radius rideal,i. This
step is performed by merging 3D spheres of radii rideal,i into the implicit representation of the
original geometry (signed distance field) and generating a new mesh from that dilated implicit
representation. Figure 3 shows an ideal model (and radius profile) superimposed over the patient
model. We omit the index i to represent the entire lumen segmentation of the appropriate radii.
Figure 3: (left) A section of a vessel with patient lumen segmentation (solid) and idealized lumen
segmentation (meshed) and (right) the corresponding patient radius (blue) and idealized patient
radius (dotted orange).
2.5 Flow dependent hemodynamic resistance
Lumen geometry influences the flowrate through the model. Therefore, quantifying the impact
of geometry on hemodynamics should account for the changes in the flowrate through the model.
The patient-specific reduced order model (PSROM) assumes an affine resistance model for flow
through the coronary arteries,
Rgeom = a(r) + b(r)Q (11)
where Rgeom is the local resistance of the lumen segmentation to blood flow, Q is the blood flow
rate, a(r) is the resistance to flow that is purely geometric, and b(r) is the sensitivity of resistance
to flowrate. This is a generalization of having a viscous (Poiseuille) and inertial (Bernoulli) term,
but the coefficients being derived from HFHC simulations instead of assuming a circular tube
cross-section and a parabolic velocity profile [33] [34].
To accurately build a response surface for a(r) and b(r), it is imperative that we explore the
space of flowrates in the patient-specific model. Since flowrate is not an independent variable,
8but rather depends on the boundary conditions and the vessel lumen geometry, we modify the
boundary conditions to change the state of the flowrate to derive b(r). We parameterize the
lumen geometry by its radius, which is commonly used for analytical 1-dimensional modeling
of the Navier-Stokes equations [33]. This modification can be done for both the patient-specific
geometry and the idealized lumen geometry, and interpolated for intermediate configurations.
Since we have chosen to use an affine model, two flowrates should suffice to explore the
space of flowrates. Since the patient-specific model is already solved for the hyperemic state,
we need only one additional flowrate. In this paper, we are interested only in dilation of the
lumen geometry (not constriction) which would result only in the increase in the rate of blood
flow. Therefore, we consider an additional state, called henceforth as “superemia”, wherein we
reduce the microvascular resistance by 40%. This number was chosen based on a grid search on
a development dataset. Smaller values such as 10% or 20% tend to have less signal to noise (low
flow difference and pressure loss compared to the numerical noise of the CFD simulations). Larger
values such as 80% tend to have flowrates very different from the modified lumen geometries. An
illustration of the hyperemia and superemia configurations on patient and idealized geometrieis
can be seen in Figure 2.
2.6 Patient-specific Reduced order model
The patient-specific reduced order model (PSROM) is constructed by first calculating a(r) and
b(r) for the original and idealized models, where two simulations are performed for each model
(hyperemia and superemia). For any new configuration, the intercept can be calculated as
a(r) = αa(rorig) + (1− α)a(rideal) (12)
where
α =
α0
r4
+ α1 (13)
α0 =
r4idealr
4
orig
r4ideal − r4orig
(14)
and
α1 =
r4orig
r4ideal − r4orig
. (15)
In addition, the slope can be calculated as
b(r) = βb(rorig) + (1− β)b(ridealized), (16)
β =
β0
A3
∂A
∂z
+ β1, (17)
β0 =
1
1
A3orig
∂Aorig
∂z − 1(Aideal)3 ∂Aideal∂z
(18)
and
β1 =
1(
1−
(
Aideal
Aorig
)3 ∂Aorig
∂z
∂Aideal
∂z
) . (19)
9Aorig and Aideal are the patient and idealized lumen areas, and derived directly from the radii.
The interpolation functions, α and β were chosen to be consistent with the Poiseuille pressure
loss and Bernoulli pressure loss respectively. A predictor corrector algorithm [35] is used to solve
the equations governing PSROM. Further details of how these quantities are calculated are given
in Algorithm 1. Figure 4 shows a schematic of the proposed patient-specific ROM approach.
2.7 Predictor corrector algorithm
The goal of the proposed method is to predict hemodynamics given a geometry modified from the
original patient’s geometry. For the modified geometry, the response surface that is constructed
from the HFHC simulations is used to estimate the coefficients a(r) and b(r) given a radius r.
These are then used to calculate the local resistances Rgeom given a flowrate Q. These resistances
are integrated from the leaves of the coronary tree using a circuit analogy (resistances are solved
in series within a given segment, and in parallel at each bifurcation). The resistances at the
ostium are then used to calculate an updated flowrate. These steps are repeated until a pre-set
convergence criterion is met. The boundary conditions depend on the hemodynamics, and we
account for this dependence by modeling the average size of the downstream vasculature being
proportional to the pressure at the outlet (passive response to increased pressure). At each outlet,
the boundary conditions are scaled from the original value by a ratio of the outlet pressures.
There are two conditions where we do not apply the interpolation approach. In regions
just downstream of the region of lumen modification, the original patient-specific geometry may
have negative resistance (increase in pressure) and thereby a negative slope. Such regions are
absent when the initial section with lumen narrowing is replaced by an idealized section. We
empirically define this potential pressure recovery region to be up to 20mm distal to a region
of vessel narrowing. This was also chosen based on the development dataset. We might miss
capturing pressure increase if we choose too small a pressure recovery region length cutoff. On
the other hand, the choice of larger region lengths may result in inclusion of recovery that are
not related to the flow features associated with a stenosis. Further, we assume that pressure can
recover only if the area gradient is negative. We therefore replace any region with negative area
gradient in the pressure recovery region with a Poiseulle resistance model. In addition, we do
not use the slope and intercept estimated from the four solutions if the hyperemic and superemic
flowrates are too close to each other. This is because numerical convergence related errors in the
HFHC model can have a non-linear effect on the slope and the intercept, and the signal to noise
effect can result in lower accuracy of the prediction, especially when flowrates of the modified
geometry are significantly larger than the original patient-specific model.
2.8 Overall Algorithm
The overall algorithm is given in Table 1 and illustrated in Figure 4. A convergence criteria
of tol2 = 2% for the ostial flowrate is used. The extraction of radii from the patient-specific
lumen segmentation and the subsequent generation of the idealized model are performed prior
to building the physics driven response surface. C represents the set of all centerline points, M
represents the set of forward neighbors (implying leaf centerline points do not have a neighbor),
Pi is the pressure at centerline point i, Qi,k is the flowrate of the section connecting i to k, ai,k
and bi,k are the slope and intercept of the section connecting centerline i to k, superscripts s
and h represent superemia and hyperemia respectively. For the predictor corrector method, the
superscripts denote the iteration number. Reff denotes the net effective downstream resistance,
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Figure 4: (A) Steps involved in generating the patient specific reduced order model. First, a
lumen segmentation of the patient anatomy is constructed from a coronary CT scan. Next,
an idealized model of the patient’s coronary tree is constructed that represents a segmentation
without lumen narrowing. Two sections of the model are highlighted to illustrate differences
between the patient and idealized models. Next, four CFD simulations are performed, two each
on the patient and idealized models with two different boundary conditions. (B) the patient
specific reduced order model (PSROM) can be used on any modified geometry that lies between
the patient and idealized geometry to calculate the hemodynamics.
and the predictor corrector method predicts the net effective resistance at each centerline point
(using reverse breadth first search from leaves to ostium), corrects the ostial flow (depth first
search from ostium to leaves), and continues until they are consistent. For the centerline point
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corresponding to the outlets, the resistances are set equal to the boundary conditions, and for the
rest of the centerline points, the resistances correspond to the geometric resistance [33] [34]. The
flow-split correction factor, γi is the deviation of the assumption (flow is inversely proportional to
the net effective downstream resisttance) in the original patient-specific geometry, defined at each
centerline point and extracted from the patient-specific hyperemic simulations. The threshold
for switching from a CFD-derived approach to a reduced order model, tol1 is chosen to be 0.1.
3 Results
In this section, we demonstrate the accuracy and speed of the proposed method against the
HFHC computational fluid dynamics model. The detailed protocol for generating the ground
truth is provided in the following section.
3.1 Validation protocol
First, we chose a cohort of patients. We identified lesions in the coronary tree of each patient,
and characterized them as single (focal), ostial, bifurcation or serial lesion. Focal lesions are
single isolated lesions present in a vessel path from ostium to the leaves. Bifurcation lesions go
across a branch, while ostial lesions occur at the junction of aorta and coronary arteries. Three
or more lesions in a vessel path were characterized as serial lesions. Any lesion type that is not
characterized as one of the four listed above were not considered as candidates for the validation
study.
For each patient and lesion type, we performed a virtual remodeling of the lesion and replaced
the geometry within the lesion with the idealized geometry. The rest of the patient’s coronary
artery tree was then blended with the remodeled region to yield a new coronary segmentation for
the patient. We then performed a CFD simulation on this geometry which serves as the ground
truth. The PSROM was run on the modified geometry and then compared against the ground
truth simulation values.
In order to obtain sufficient statistical power, we chose thirteen hundred and forty one (1341)
patients. Ten of these failed to yield a ground truth FFRCT due to meshing or convergence
issues. Therefore, a total of thirteen hundred and thirty one (1331) cases were available and
were used to evaluate the PSROM.
The cases were gathered from centers in the US, Japan, EU, and UK and were not used for
development or validation of the algorithm. Lesions that were modified had to exhibit a lumen
narrowing of at least 30% using the metric defined in Sankaran et al. [36] with rideal being used
for the healthy or ideal radius. Samples of the different lesion types along with their idealized
lumen geometry are shown in Figure 5.
For each case, we evaluated results at salient points downstream of the lumen modification
but avoided bifurcation or pressure recovery regions. In some cases, more than one comparison
location was identified. In total, 2578 comparisons across 1331 patient-specific models were
performed.
In order to demonstrate equivalence, we tested that the bias is within 0.01 and the standard
deviation is within 0.02. The numbers are motivated primarily by a mesh independence study on
the ground truth values, which demonstrated that if we were to replace FFRCT with a very fine
mesh, the 95% confidence interval of error is within 0.03, which translates to a standard deviation
of ∼ 0.02. To demonstrate equivalence in bias, we used a two one-sided t-test (TOST) and to
12
Algorithm 1 Overview of the algorithm to build and predict hemodynamics using a patient-
specific reduced order model.
BUILDING PHYSICS DRIVEN RESPONSE SURFACE
Solve the HFHC model in four configurations.
for ci ∈ C do
for ck : ck ∈M(ci) do
bi,k =
(P si −P sk )/Qsi,k−(Phi −Phk )/Qhi,k
Qsi,k−Qhi,k
ai,k =
(P si −P sk )Qhi,k/Qsi,k−(Phi −Phk )Qsi,k/Qhi,k
Qhi,k−Qsi,k
if Qsi,k −Qhi,k <= tol1 ∗Qhi,k then
ai,k =
8µL
pir4
bi,k = ρ
1
A3
(
∂A
∂z
)
end if
end for
end for
SOLVING PSROM
Initialize n = 0, ostial flow (O0q), the superscript denoting the iteration number, n
while n == 0 or Onq −On−1q > tol2 ×On−1q do
n = n + 1
Rni,k = ai,k + bi,kQ
n−1
i,k
enqueue(leaf)
while ( do queue not empty)
rbfs(pop queue)
end while
Onq =
Paorta
OnReff
; Qn = dfs(ostium)
end while
function dfs(current node = m)
if is outlet(current node) then return
end if
if is branch(current node) then Qmd1 = Qm × Reff,mReff,d1 × γmd1 ; Qmd2 = Qm ×
Reff,m
Reff,d2
× γmd2
dfs(md1)
dfs(md2)
else
for k : k ∈M(m) do Qk = Qm.
dfs(k)
end for
end if
end function
function rbfs(current node = m)
if is ostium(current node) then return
end if
if is branch(current node) then
for k : k ∈M(m) do Rlocal+ = 1/Ri,k.
Reff,i =
1
Rlocal
end for
else
for k : k ∈M(m) do
Reff,i+ = Ri,k.
end for
end if
enqueue(m-1)
end function
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demonstrate equivalence in standard deviation, we used a chi-squared test. The null hypothesis
for the TOST test is the absolute difference between the proposed method and ground truth
is less than 0.03. The null hypothesis for the chi-squared test is that the standard deviation is
greater than 0.02.
A B
C
D
Figure 5: Patient lumen segmentation (solid) in a section of the vessel superimposed with the
ideal lumen segmentation (meshed) for (A) ostial lesion, (B) bifurcation lesion, (C) focal (single)
lesion, and (D) serial lesion.
3.2 Performance
The overall bias in the evaluated dataset was 0.00524, with a corresponding p-value using TOST
(two one-sided t-test) of <1e-3. The standard deviation in the evaluated dataset was 0.0147,
with a corresponding p-value using chi-squared test of <1e-3. The correlation coefficient between
FFRCT and PSROM was 0.982 (95% CI 0.981-0.984, p<0.001). The 95% Bland-Altman limits
of agreement between FFRCT and FFRPSROM was (-0.020, 0.031) as seen in Figure 7. These are
within the 95% confidence intervals of measurement reproducibility. Slope and intercept were
observed to be 0.972 and 0.030 respectively.
The mean difference of FFRCT before and after modification was 0.111 with a standard
deviation of 0.121. The maximum change in FFRCT before and after lumen modification was
0.70. For those locations where the change in FFRPSROM before and after modification was
greater than 0.1 (N = 1082), the bias and standard deviation were 0.006 and 0.020 respectively.
For locations where the change in FFR using PSROM before and after modification was less than
0.1 (N = 1496), a bias of 0.004 and standard deviation of error of 0.009 was observed. This also
demonstrates that the proposed method is able to predict FFRCT for large and small changes
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lesion type sample size bias standard deviation 95% CI
bifurcation 782 0.0051 0.0171 (-0.028, 0.039)
ostial 78 0.0089 0.0153 (-0.021, 0.039)
focal 465 0.0030 0.0149 (-0.014, 0.019)
serial 1253 0.0059 0.0084 (-0.023, 0.035)
overall 2578 0.0052 0.0148 (-0.020, 0.031)
Table 1: Performance of the proposed method categorized by lesion type. Bias, standard devia-
tion and 95% confidence intervals are reported along with the sample size.
before and after modification. Ninety five percent of all the comparisons had an error of less
than 0.03 compared to FFRCT.
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Figure 6: (left) Run times of the proposed method with a median of 0.53 seconds, (right) A
comparison of the average and standard deviation (stdev) of the full solver and the PSROM
method plotted in a logarithmic scale.
The average time taken to execute the PSROM algorithm for the prediction step was 0.59±
0.30 sec (median 0.53 sec). The maximum time taken was 2.22 sec with a 75th percentile value
of 0.75 sec. Figure 6 shows the histogram of duration of the PSROM algorithm on an iPad Pro
10.5 device. Average and standard deviation of run times across the entire population are shown
for the ground truth and the PSROM methods (in logarithmic scale).
Further, the results were analyzed based on stratification by lesion type. For bifurcation
lesions (N = 782), bias was 0.005 (p<1e-6) and standard deviation of error was 0.017 (p<1e-6).
For serial lesions (N = 1253), bias was 0.006 (p<1e-6) and standard deviation of error was 0.008
(p<1e-6). For focal lesions (N = 465), bias was 0.003 (p<1e-6) and standard deviation of error
was 0.015 (p<1e-6). For ostial lesions (N = 78), bias was 0.009(p=0.25) and standard deviation
of error was 0.015 (p=0.004). The N corresponds to the number of comparisons, which may
include more than one per patient. Table 1 summarizes these results.
Table 2 summarizes performance of the algorithm when data was stratified based on FFRPSROM
in different ranges (or buckets). Each bucket has a different sample size which is expected based
on a typical randomized patient population. The bias is the highest in the bucket with smallest
FFRCT and the standard deviation is highest in the [0.70, 0.75) bucket.
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range N bias standard deviation
[0.00, 0.70) 74 0.0160 0.0261
[0.70, 0.75) 84 0.0035 0.0394
[0.75, 0.80) 151 0.0081 0.0214
[0.80, 0.85) 309 0.0069 0.0165
[0.85, 0.90) 558 0.0068 0.0149
[0.90, 1.00] 1402 0.0035 0.0080
Table 2: Performance of the proposed method stratified by FFRPSROM. Bias and standard
deviation are reported along with the sample size.
Figure 8 demonstrates error properties of the FFR results of the PSROM method. It demon-
strates that the error distribution is centered close to a mean of zero, and has a normal dis-
tribution around the mean. In addition, the figure also demonstrates the added value of the
proposed method against a ROM either not accounting for the vessels with low flow difference
or not accounting for the pressure recovery.
Figure 9 shows pressure tracing in three vessels with serial lesions with superimposed traces of
the FFRCT of the patient model before and after modification and FFRPSROM. These examples
demonstrate the ability of the PSROM method to capture the pressure drop in tandem lesions
with higher flowrate post lumen modification.
3.3 Validation against invasive data
We also clinically validated the PSROM method using invasive data obtained from percutaneous
coronary intervention (PCI) or stenting procedures. PCI is the process of inserting a catheter
with a balloon attached to restore and attain ideal lumen geometry on a section of the blood
vessel. The objective of this procedure is to relieve symptoms of ischemia and mitigate risk of
coronary artery disease. Some of the biggest challenges of PCI is to know a-priori which lesions
have the largest impact on FFR (for serial lesions), how stenting may restore blood flow (for
all lesion types, with diffuse atherosclerosis potentially not increasing coronary blood flow even
after restoring vessel caliber), or how to size the stent (radius and length). The PSROM method
was first applied to a patient with serial lesions where the invasive FFR was also measured [37].
Two lesions (A - proximal and B - distal) were identified in the left arterior descending (LAD)
artery. Invasive revascularization of B and a combination of A and B were performed. We
applied the PSROM, blinded, to these two configurations, and demonstrated excellent match
for the two scenarios (lesion B - invasive 0.77, PSROM 0.79, and lesion A + B - invasive 0.85,
PSROM 0.88). We also applied the PSROM method to a cohort of thirteen patients with serial
lesions who underwent PCI [38]. The use of PSROM improved the correlation coefficient of the
comparison to 0.75 over a value of 0.44 using conventional FFRct (p < 0.001). Further, the bias
and coefficient of variation of PSROM was 0.01 and 7% respectively, compared to 0.05 and 37%
using pre-PCI values.
4 Discussion
We formulated and developed a method, called PSROM, that enables fast assessment of hemo-
dynamics in response to modifying a patient-specific geometry. The method was built on the two
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Figure 7: (A) Scatterplot comparing the ground truth (FFRCT) solution obtained by solving
the Navier-Stokes equations (HFHC model) to the solution obtained using the patient-specific
reduced order model (FFRPSROM). (B) Bland-Altman plot showing the error as a function of the
average values, along with the bias and 95% limits of agreement, (C-F) Scatterplot comparing
FFRPSROM to FFRCT in modifications with ostial, bifurcation, serial and single (focal) disease
respectively.
principles. First, resistance of lumen geometry to flow was modeled to have a linear relationship
with the flowrate, with the slope and intercept being functions of arterial geometry. This was
primarily motivated by the steady-state solution to a 1-dimensional Navier-Stokes equation that
has a linear and quadratic term for pressure loss. Second, flow split at bifurcations was modeled
to be inversely related to the net downstream resistance of the respective vessels. Net down-
stream resistance accounts for both the geometric resistance as well as the boundary conditions.
Additionally, we assumed that the idealized model represents the largest possible dilation of the
CT derived lumen geometry, though the method outlined in this work is applicable even if the
strategy to define idealized model is different.
We initially built a local space around a patient-specific geometry that was constrained by a
maximum possible geometric expansion using a patient-specific idealized model. The idealized
model was derived from the patient’s lumen segmentation by fitting a radius profile that is non-
increasing from the root to the leaves. The idealized model represents a patient-specific lumen
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Figure 8: Illustration of the properties of the error between FFRCT and FFRPSROM distributions.
(A) Error distribution in different FFRPSROM ranges. (B) error histogram in the evaluation
dataset, (C-F) error distributions corresponding to (red) unconstrained, (orange) hybrid based
on a ROM cutoff, and (green) hybrid with a pressure recovery fix term, which was used for all
the results in this paper.
segmentation without regions of lumen narrowing that is the closest in L-1/2 norm with the
original lumen segmentation. Further, we used a sampling of different microvascular properties
(dilation) to derive the properties of the affine model. In this work, we define this space using
four configurations, two different lumen segmentations (patient and idealized model) and two
boundary conditions each. The two geometric configurations were chosen to be the extrema of
the lumen segmentation (patient and idealized). The boundary conditions were chosen to be
hyperemia, and another lower resistance that we call superemia, which has 40% less resistance
and allows more flow through the vessels. This, in turn, enables the PSROM to parameterize
the intercept and slope. A physics driven response surface was used to represent the resistance
of geometry to flow within this patient-specific exploration space.
We deviated from the formulation to consider two special situations - (i) if the vessel is severely
diseased such that flowrate is limited by geometry, then there is insufficient flow separation
between the hyperemic and superemic conditions. In such situations, we used a model that is
not derived from the HFHC simulations, but rather uses the analytical reduced order model (1D
Navier-Sokes equations) constrained by the hyperemic patient and ideal model hemodynamics,
(ii) in the sub-regions within the coronary tree where pressure recovers, i.e. pressure increases as
we traverse the vessel tree from the proximal to distal section. These are regions where a reduced
order model interpolation does not work because geometric resistance is negative. Therefore, we
replace the interpolatory behavior by using an analytical model in the “pressure recovery” zone
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Figure 9: FFR tracing from the ostium to a distal end of a modified vessel, comparing the
original trace, PSROM prediction and ground truth.
(that we define in this work as within 20 mm from the stent). The results showed that these
developments were needed to achieve the desired performance.
In order to accurately capture pressure recovery, models for smaller scale fluid structures
such as eddies and turbulence need to be captured. The value of 20 mm used in this paper was
based on empirical observation in the development dataset, but this can be improved further by
understanding the link between lumen geometry, flowrate and the resultant pressure recovery
region length and extent.
The method we proposed was validated against a large cohort of patients with different lesion
characteristics: namely, bifurcation, serial, single and ostial lesions. The method performed very
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well against the ground truth CFD simulations in over 2500 evaluation points. This was enabled
by deriving the ROM directly from set of CFD simulations, thereby negating the scenarios where
other low dimensional models perform poorly due to a combination of various factors such as (i)
assuming a parabolic velocity profile, (ii) approximating geomety by radius, and/or (iii) failing
to account for turbulent losses. Leveraging the patient-specific model to model pressure recovery,
except the region just downstream of the modified region, also helped improve the performance
over traditional reduced order models. The method also performed well against invasive data on
a cohort of patients who underwent PCI. To our knowledge, no published method in literature
has demonstrated such good performance. The technique was recently cleared by the U.S. Food
and Drug Administration (FDA) for clinical use.
The proposed method showed significant discriminatory power in predicting the FFRCT post
modification compared to the ground truth three dimensional CFD simulations. Additionally, we
demonstrated a good correlation coefficient, Bland-Altman limits of agreement, and agreement
across lesion types. Two sets of clinical studies [38, 37], where the invasive measurements were
blinded, showed promising results when compared with PSROM.
The method performed well in identifying “silent lesions”, those that are masked by another
severe lesion in the same vessel path. Relieving the lumen narrowing in a flow-limiting lesion
results in more flow through the tandem (less severe) lesion (refer Fig. 9). Consequently, this will
result in a higher pressure drop across the unmodified lesion. The results we obtained demon-
strated that the proposed method is able to capture this increase in pressure drop accurately.
The proposed method does not fully account for changes to the patient post-intervention such
as potential plaque shift, side branch jailing, and the material used for lumen dilation. Further,
the changes to the microvascular resistance are modeled only with regards to passive remodeling
of the vessel wall (relationship of area to flow). Finally, the performance in modifications with a
large change was not on par with the performance in healthier sections.
We believe that the method outlined in this work has the potential to aid interventional
procedural planning by its ability to virtually model different scenarios before performing the
actual intervention. This could potentially increase cath lab efficiency by reducing unnecessary
procedures, procedural duration, total radiation dose as well as highlight scenarios that might
be missed by visual inspection of an angiogram.
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